New hope for untreated lung cancer patients in clinical trial
NCT ID NCT07005336
Summary
This study is testing whether adding a new drug called uliledlimab to standard immunotherapy and chemotherapy works better for advanced lung cancer patients who haven't had prior treatment. About 150 patients with stage IIIB-IV non-small cell lung cancer will receive either the new combination or the standard treatment. The main goal is to see which approach keeps the cancer from growing longer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Anhui Provincial Cancer Hospital
Hefei, China
-
Beijing Chest Hospital
Beijing, China
-
Binzhou Medical University Hospital
Binzhou, China
-
Chongqing University Three Gorges Hospital
Chongqing, China
-
First Hospital of Shanxi Medical University
Taiyuan, China
-
General Hospital of Ningxia Medical University
Yinchuan, China
-
Guangxi Medical University Cancer Hospital
Nanning, China
-
Harbin Medical University Cancer Hospital
Ha’erbin, China
-
Hubei Cancer Hospital
Wuhan, China
-
Jiangmen Central Hospital
Jiangmen, China
-
Linyi People's Hospital
Linyi, China
-
Lishui Central Hospital
Lishui, China
-
Shanghai Chest Hospital
Shanghai, China
-
Shanxi Provincial Cancer Hospital
Taiyuan, China
-
Sichuan Cancer Hospital
Chengdu, China
-
The First Affiliated Hospital of Anhui Medical University
Hefei, China
-
The First Affiliated Hospital of Guangxi Medical University
Nanning, China
-
The First Affiliated Hospital of Nanchang University
Nanchang, China
-
The First Affiliated Hospital of Wenzhou Medical University
Wenzhou, China
-
The First Affiliated Hospital of Xi'an Jiaotong University
Xi'an, China
-
The First Affiliated Hospital of Xinxiang Medical University
Xinxiang, China
-
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, China
-
The Second Affiliated Hospital of Xi'an Jiaotong University
Xi'an, China
-
The Second People's Hospital of Neijiang
Neijiang, China
-
The Second People's Hospital of Yibin
Yibin, China
-
Xiangyang Central Hospital
Xiangyang, China
-
Yunan Cancer Hospital
Kunming, China
-
Zhoukou Central Hospital
Zhoukou, China
Conditions
Explore the condition pages connected to this study.